Home / Latest Science News -- ScienceDaily / Common diabetes drug shows promise as treatment for COVID-19 lung inflammation

Common diabetes drug shows promise as treatment for COVID-19 lung inflammation

Researchers identify the molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.

from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/06/210610162401.htm
Common diabetes drug shows promise as treatment for COVID-19 lung inflammation Common diabetes drug shows promise as treatment for COVID-19 lung inflammation Reviewed by cmakigo on June 11, 2021 Rating: 5

You May Also Like

No comments:

Post a Comment

Subscribe to: Post Comments ( Atom )
'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();
Powered by Blogger.